MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
Psoriasis: Treatment and Pathogenesis
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

2,393 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
2,393 works in the cohort · of 4,299,418page 24 of 48

Labels cover 8 of 2,393 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 2,393 of 2,393 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affaboutunlabeled
Topical Roflumilast for Plaque Psoriasis.
Ashley O’Toole, Melinda Gooderham
2023· article· en· PubMed· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
8
citations
affaboutunlabeled
Guselkumab for Moderate to Severe Psoriasis Across All Skin Tones
Andrew Alexis, Amy McMichael, Jennifer Soung, Olivia Choi, Theodore Alkousakis, Javier Alonso‐Llamazares +20 more
2025· article· en· JAMA Dermatology· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
8
citations
affunlabeled
Defining On-Treatment Remission in Plaque Psoriasis
George Gondo, Joseph F. Merola, Alyssa Roberts, Lourdes M. Pérez-Chada, Deepak Balak, Guy S. Eakin +32 more
2025· article· en· JAMA Dermatology· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
8
citations
aboutno affunlabeled
Psychological Aspects of Cutaneous Pain in Psoriasis
Magdalena Kotewicz, Piotr K. Krajewski, Andrzej Jaworek, Jacek C. Szepietowski
2024· article· en· Journal of Clinical Medicine· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
7
citations
affaboutunlabeled
Update on Alefacept Safety
Denise Wexler, Gordon E. Searles, Ian Landells, Neil H. Shear, Robert Bissonnette, Kim Papp +3 more
2009· article· en· Journal of Cutaneous Medicine and Surgery· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
7
citations
affno abstractunlabeled
Potential future therapies for psoriasis
Kim Papp
2005· review· en· Seminars in Cutaneous Medicine and Surgery· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
7
citations

How this was built: Screen · Findings · About